Atlas Trials

A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.

Clinical trial NCT01928368 · COMPLETED

Trial details

NCT number
NCT01928368
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Asthma
Start date
2013-08-01
Primary completion
2016-03-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.